Table 1.
Worldwide incidence and rates by sex for the 29 cancer types in 2019 in adults over 75 years old and the change in the trends from 1990 to 2019
| Both sexes | Male | Female |
1990–2019 EAPC No. (95% CI) |
||||
|---|---|---|---|---|---|---|---|
| Case | Rate per 100,000 | Case | Rate per 100,000 | Case | Rate per 100,000 | ||
| Total cancer | 6,746,260 | 2439.10 | 3,808,334 | 3302.68 | 2,937,926 | 1821.66 | 0.64(0.73–0.56) |
| Non-melanoma skin cancer | 2,342,592 | 846.96 | 1,352,247 | 1172.70 | 990,344 | 614.06 | 1.36(1.52–1.21) |
| Colon and rectum cancer | 699,550 | 252.92 | 354,675 | 307.58 | 344,876 | 213.84 | 0.39(0.66–0.13) |
| Lung cancer | 684,689 | 247.55 | 436,009 | 378.12 | 248,680 | 154.19 | 0.90(1.17–0.62) |
| Prostate cancer | 503,226 | 181.94 | 503,226 | 436.41 | – | – | -0.07(0.24–0.37) |
| Stomach cancer | 382,531 | 138.30 | 229,360 | 198.91 | 153,171 | 94.97 | -0.65(-0.32–0.98) |
| Breast cancer | 316,955 | 114.59 | 4988 | 4.33 | 311,968 | 193.44 | -0.17(0.21–0.55) |
| Bladder cancer | 199,743 | 72.22 | 147,699 | 128.09 | 52,044 | 32.27 | 0.26(0.75–0.24) |
| Pancreatic cancer | 189,062 | 68.36 | 82,709 | 71.73 | 106,353 | 65.94 | 1.08(1.62–0.54) |
| Non-Hodgkin lymphoma | 148,100 | 53.55 | 74,830 | 64.89 | 73,269 | 45.43 | 0.94(1.54–0.34) |
| Esophageal cancer | 145,722 | 52.69 | 94,080 | 81.59 | 51,642 | 32.02 | -0.11(0.44–0.66) |
| Liver cancer | 132,488 | 47.90 | 78,330 | 67.93 | 54,158 | 33.58 | -0.06(0.54–0.65) |
| Leukemia | 130,715 | 47.26 | 68,928 | 59.78 | 61,786 | 38.31 | 0.56(1.18–0.06) |
| Kidney cancer | 84,392 | 30.51 | 49,985 | 43.35 | 34,407 | 21.33 | 1.20(2.00–0.40) |
| Gallbladder and biliary tract | 80,579 | 29.13 | 32,630 | 28.30 | 47,949 | 29.73 | -0.26(0.49–1.00) |
| Lip and oral cavity cancer | 69,899 | 25.27 | 38,349 | 33.26 | 31,550 | 19.56 | 0.33(1.19–0.51) |
| Malignant skin melanoma | 68,290 | 24.69 | 36,981 | 32.07 | 31,309 | 19.41 | 1.72(2.64–0.81) |
| Uterine cancer | 66,233 | 23.95 | – | – | 66,233 | 41.07 | -0.04(0.78–0.86) |
| Multiple myeloma | 52,776 | 19.08 | 26,692 | 23.15 | 26,084 | 16.17 | 0.44(1.41–0.52) |
| Brain and central nervous | 50,752 | 18.35 | 23,800 | 20.64 | 26,953 | 16.71 | 1.57(2.64–0.51) |
| Ovarian cancer | 49,447 | 17.88 | – | – | 49,447 | 30.66 | -0.37(0.58–1.31) |
| Cervical cancer | 45,564 | 16.47 | – | – | 45,564 | 28.25 | -0.88(0.07–1.83) |
| Larynx cancer | 36,108 | 13.05 | 30,017 | 26.03 | 6091 | 3.78 | -0.23(0.91–1.35) |
| Thyroid cancer | 24,888 | 9.00 | 8917 | 7.73 | 15,971 | 9.90 | 0.71(2.16–0.71) |
| Other pharynx cancer | 22,414 | 8.10 | 15,921 | 13.81 | 6493 | 4.03 | 1.39(3.04–0.22) |
| Nasopharynx cancer | 14,795 | 5.35 | 9731 | 8.44 | 5064 | 3.14 | 0.75(2.72–1.19) |
| Hodgkin lymphoma | 13,056 | 4.72 | 7188 | 6.23 | 5868 | 3.64 | 0.44(2.44–1.52) |
| Mesothelioma | 11,864 | 4.29 | 9087 | 7.88 | 2777 | 1.72 | 0.31(2.34–1.69) |
| Testicular cancer | 2789 | 1.01 | 2789 | 2.42 | – | – | 1.11(5.80–3.37) |
| Other malignant neoplasms | 177,040 | 64.01 | 89,167 | 77.33 | 87,873 | 54.49 | 1.10(1.66–0.55) |
EAPC estimated annual percentage change